Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 9/20 | 0.54 |
| ▸ | RAB9A | P51151 | 9/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 8/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.54 |
| ▸ | HPGD | P15428 | 5/20 | 0.54 |
| ▸ | CASP3 | P42574 | 3/20 | 0.54 |
| ▸ | SENP7 | Q9BQF6 | 3/20 | 0.54 |
| ▸ | SENP6 | Q9GZR1 | 3/20 | 0.54 |
| ▸ | POLB | P06746 | 3/20 | 0.54 |
| ▸ | SENP8 | Q96LD8 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.48 |
| ▸ | MAPT | P10636 | 5/20 | 0.48 |
| ▸ | MEN1 | O00255 | 5/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | ELANE | P08246 | 1/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.46 |
| ▸ | PTPN2 | P17706 | 3/20 | 0.44 |
| ▸ | PTPN5 | P54829 | 3/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21166598 | 0.92 | NPC1 (0.54) | NPC1RAB9ASMN1; SMN2KDM4EHPGD | |
| SCHEMBL15773552 | 0.88 | NPC1 (0.44) | NPC1RAB9ASMN1; SMN2KDM4EHPGD | |
| SCHEMBL9018554 | 0.86 | NPC1 (0.68) | NPC1RAB9ASMN1; SMN2KDM4EHPGD | |
| SCHEMBL903716 | 0.83 | NPC1 (0.64) | NPC1RAB9ASMN1; SMN2KDM4EHPGD | |
| SCHEMBL15413714 | 0.81 | NPC1 (0.66) | NPC1RAB9ASMN1; SMN2KDM4EHPGD | |
| SCHEMBL24550892 | 0.79 | SMN1; SMN2 (0.43) | NPC1RAB9ASMN1; SMN2KDM4EHPGD | |
| SCHEMBL9683245 | 0.78 | NPC1 (0.62) | NPC1RAB9ASMN1; SMN2KDM4EHPGD | |
| SCHEMBL26745313 | 0.78 | SMN1; SMN2 (0.67) | NPC1RAB9ASMN1; SMN2KDM4EHPGD | |
| SCHEMBL19601391 | 0.77 | NPC1 (0.76) | NPC1RAB9ASMN1; SMN2KDM4EHPGD | |
| SCHEMBL14193959 | 0.77 | SMN1; SMN2 (0.66) | NPC1RAB9ASMN1; SMN2KDM4EHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10985327-B2 | Microcrystalline organic semiconductor film, organic semiconductor transistor, and method of manufacturing organic semiconductor transistor | FUJIFILM CORPORATION (JP) | 2021-04-20 | — | — | US | disclosed |
| US-20190237677-A1 | MICROCRYSTALLINE ORGANIC SEMICONDUCTOR FILM, ORGANIC SEMICONDUCTOR TRANSISTOR, AND METHOD OF MANUFACTURING ORGANIC SEMICONDUCTOR TRANSISTOR | FUJIFILM CORPORATION (JP) | 2019-08-01 | — | — | US | disclosed |
| US-20190221754-A1 | BOTTOM GATE TYPE ORGANIC SEMICONDUCTOR TRANSISTOR | FUJIFILM CORPORATION (JP) | 2019-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190237677-A1 | MICROCRYSTALLINE ORGANIC SEMICONDUCTOR FILM, ORGANIC SEMICONDUCTOR TRANSISTOR, AND METHOD OF MANUFACTURING ORGANIC SEMICONDUCTOR TRANSISTOR | OR10J3, ALK, MSMO1 | NPC1 2154/4885RAB9A 1473/4885SMN1; SMN2 3981/4885 |
| US-10985327-B2 | Microcrystalline organic semiconductor film, organic semiconductor transistor, and method of manufacturing organic semiconductor transistor | OR10J3, ALK, MSMO1 | NPC1 2154/4885RAB9A 1473/4885SMN1; SMN2 3981/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.